Chris Hayes, EVP, GM, Prognos Health

Healthcare leaders are rethinking how campaigns move from draft to market. AI promises faster content creation and shorter MLR cycles, but executives face new questions: How do we balance speed with regulatory scrutiny? How do we preserve the authentic voice of science and patient trust? This panel brings together industry leaders to share perspectives on what’s working, where the pitfalls lie, and how to build responsible, future-ready processes.

• Exploring practical use cases where AI drafting and pre-checks deliver measurable time savings
• Using AI to support – not replace – MLR teams, streamlining collaboration across functions
• Establishing guardrails to protect scientific accuracy and preserve brand credibility
• Partnering with regulators to align expectations and co-create best practices

Patient influencers are shaping conversations about treatments, disease awareness, and quality of life. But the rise of patient voices creates debate: Are they trusted advocates, or an extension of pharma’s paid campaigns? This session features an executive-level debate between industry leaders, challenging attendees to weigh the value, risks, and future of patient influence in pharma.

• Evaluating impact by scale and authenticity and understanding when to leverage macro reach vs. micro/patient authenticity
• Building influencer strategies that are transparent, ethical, and regulator-ready to balance influence with compliance
• Exploring hybrid approaches that combine patient voices with traditional campaigns to build trust and reach